Transplant Complication

1
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MaaT Pharma
MaaT PharmaFrance - Lyon
1 program
1
Pooled allogeneic fecal microbiotherapyPhase 21 trial
Active Trials
NCT05762211RecruitingEst. Feb 2027

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
MaaT PharmaPooled allogeneic fecal microbiotherapy

Clinical Trials (1)

NCT05762211MaaT PharmaPooled allogeneic fecal microbiotherapy

Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

Start: Oct 2023Est. completion: Feb 2027
Phase 2Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space